AGP Picks
View all

The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on July 21, 2026

Celldex Reports Results from Phase 2 Study of Barzolvolimab in Prurigo Nodularis
Chairman Transition and Board Changes
Binaxity Introduces Gold Investment Line of Credit Backed by Tether Gold (XAUt)
Together for Haiti Joins Together for Haiti Matching Campaign to Address Food Insecurity in Northern Haiti
Tauro Markets Recognized as the  Global Winner of Best IB &  Affiliation Program 2026 by Gazet  International
Bitget améliore l’expérience du trading algorithmique grâce à l’intégration des SDK de Sirbly.io
ビットゲット、Siebly.ioのSDK統合によりアルゴリズム取引の体験を向上
Bitget, Siebly.io SDK 연동으로 알고리즘 거래 개발 환경 강화
Bitget 集成 Siebly.io SDK,提升算法交易体验
Bitget mejora la experiencia del trading algorítmico con la integración de SDK de Siebly.io
Bitget משפרת את חוויית המסחר האלגוריתמי עם שילוב ה-SDK של Siebly.io
Bitget Mempertingkatkan Pengalaman Dagangan Algoritma dengan Integrasi SDK Siebly.io
Bitget Aprimora Experiência de Negociação Algorítmica com a Integração do SDK da Siebly.io
Bitget 透過 Siebly.io SDK 整合,提升演算法交易體驗
SK pharmteco und Genethon demonstrieren die Stärke des Produktionsstandorts Frankreich für das richtungsweisende DMD-Gentherapieprogramm
SK pharmteco et Généthon mettent en avant l’excellence de la fabrication française à l’origine du programme pivot de thérapie génique contre la DMD
Bitget Emerges as a Leading TradFi Trading Venue With Nearly $70B in Q2 Perpetual Volume, TokenInsight Report Finds
NOTICE TO DISREGARD -- Critical Metals Corp
SK pharmteco and Genethon Showcase French Manufacturing Strength Behind Pivotal DMD Gene Therapy Program
Bitget Enhances Algorithmic Trading Experience with Siebly.io SDK Integration

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The LATAM Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.